Pregnancy associated plasma protein-A as a marker for myocardial infarction and death in patients with stable coronary artery disease: A prognostic study within the CLARICOR Trial-Reference-Cited by-同舟云学术

Pregnancy associated plasma protein-A as a marker for myocardial infarction and death in patients with stable coronary artery disease: A prognostic study within the CLARICOR Trial

Published:2011-01 Issue:1 Volume:214 Page:203-208
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Iversen Kasper K.,Teisner Børge,Winkel Per,Gluud Christian,Kjøller Erik,Kolmos Hans Jørn,Hildebrandt Per Rossen,Hilden Jørgen,Kastrup Jens

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies. Part II;Naghavi;Circulation,2003

2. Pregnancy-associated plasma protein a as a marker of acute coronary syndromes;Bayes-Genis;N Engl J Med,2001

3. The long-term prognostic value of multiple biomarkers following a myocardial infarction;Brugger-Andersen;Thromb Res,2008

4. Usefulness of pregnancy-associated plasma protein a in patients with acute coronary syndrome;Iversen;Am J Cardiol,2009

5. Pregnancy associated plasma protein a, a novel, quick, and sensitive marker in st-elevation myocardial infarction;Iversen;Am J Cardiol,2008

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers to monitor the prognosis, disease severity, and treatment efficacy in coronary artery disease;Expert Review of Cardiovascular Therapy;2023-10-03

2. The STC2–PAPP-A–IGFBP4–IGF1 axis and its associations to mortality and CVD in T2D;Endocrine Connections;2023-03-01

3. Novel Cardiovascular Biomarkers Associated with Increased Cardiovascular Risk in Women With Prior Preeclampsia/HELLP Syndrome: A Narrative Review;European Cardiology Review;2021-09-24

4. Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease. A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial;BMJ Open;2020-08

5. Pregnancy Associated Plasma Protein-A as a Cardiovascular Risk Marker in Patients with Stable Coronary Heart Disease During 10 Years Follow-Up—A CLARICOR Trial Sub-Study;Journal of Clinical Medicine;2020-01-18